Literature DB >> 12504913

Gabapentin-- actions on adult superficial dorsal horn neurons.

K A Moore1, H Baba, C J Woolf.   

Abstract

Despite identification of GABA(B) receptors with gb1a-gb2 composition and the alpha2delta calcium channel subunit as putative molecular targets for gabapentin (GBP), its cellular mechanism of action has remained elusive. Therefore, we have used an in vitro spinal cord slice preparation to study the effects of GBP on lamina II neurons. The frequency and amplitude of spontaneous EPSCs and IPSCs were unaffected by GBP, suggesting presynaptic neurotransmitter release is not regulated. Direct modulation of postsynaptic membrane excitability is also unlikely since the level of holding current required to maintain neurons at -70, 0 and +45 mV was unaffected by GBP. Effects on excitatory and inhibitory synaptic transmission were variable across the population. Primary afferent-evoked fast glutamatergic EPSCs were unaffected by GBP, while evoked NMDA receptor-mediated EPSCs and IPSCs were variably affected. In contrast, GBP enhanced responses to bath applied NMDA in 71% of neurons. Thus, in adult rat dorsal horn, synaptic and extrasynaptic NMDA receptors may be differentially regulated by GBP perhaps due to differences in subunit composition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12504913     DOI: 10.1016/s0028-3908(02)00226-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans.

Authors:  G D Iannetti; L Zambreanu; R G Wise; T J Buchanan; J P Huggins; T S Smart; W Vennart; I Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

2.  Electrophysiological characterization of spinal neuron sensitization by elevated calcium channel alpha-2-delta-1 subunit protein.

Authors:  C Zhou; Z D Luo
Journal:  Eur J Pain       Date:  2013-10-23       Impact factor: 3.931

3.  Nerve injury-induced calcium channel alpha-2-delta-1 protein dysregulation leads to increased pre-synaptic excitatory input into deep dorsal horn neurons and neuropathic allodynia.

Authors:  C Zhou; Z D Luo
Journal:  Eur J Pain       Date:  2015-02-17       Impact factor: 3.931

4.  The effects of intrathecal and systemic gabapentin on spinal substance P release.

Authors:  Toshifumi Takasusuki; Tony L Yaksh
Journal:  Anesth Analg       Date:  2011-03-08       Impact factor: 5.108

5.  Identity of myelinated cutaneous sensory neurons projecting to nocireceptive laminae following nerve injury in adult mice.

Authors:  C Jeffery Woodbury; Florenta A Kullmann; Sabrina L McIlwrath; H Richard Koerber
Journal:  J Comp Neurol       Date:  2008-05-20       Impact factor: 3.215

Review 6.  Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.

Authors:  Marcello Tonini; Roberto De Giorgio; Fabrizio De Ponti
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states.

Authors:  Jose A Martinez; Manami Kasamatsu; Alma Rosales-Hernandez; Leah R Hanson; William H Frey; Cory C Toth
Journal:  Mol Pain       Date:  2012-01-11       Impact factor: 3.395

8.  The Effect of Once-Daily Gabapentin Extended Release Formulation in Patients With Postamputation Pain.

Authors:  Nebojsa Nick Knezevic; Tabish Aijaz; Kenneth D Candido; Svetlana Kovaleva; Alexei Lissounov; Ivana Knezevic
Journal:  Front Pharmacol       Date:  2019-05-15       Impact factor: 5.810

Review 9.  Postcraniotomy Headache: Etiologies and Treatments.

Authors:  Corina Bello; Lukas Andereggen; Markus M Luedi; Christian M Beilstein
Journal:  Curr Pain Headache Rep       Date:  2022-03-01

10.  Recombinant neural progenitor transplants in the spinal dorsal horn alleviate chronic central neuropathic pain.

Authors:  Stanislava Jergova; Shyam Gajavelli; Nirmal Pathak; Jacqueline Sagen
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.